Equilife Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -60.94%
- Profit Growth -422.25%
- Ebitda -216.23%
- Net Worth -87.04%
- Total Assets -3.52%
About Equilife Laboratories
Equilife Laboratories Private Limited (ELPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2019 (Five years and six months 11 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ukha Singare, Dnyaneshwar Singare, and Shubhangi Pagar serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230PN2019PTC186087
- Company No.
186087
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Equilife Laboratories Private Limited offer?
Equilife Laboratories Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Pharma Ingredients & Raw Materials, API Intermediate, Anti Infective Drugs & Medicines, Antibacterial Drugs, Computer & Mobile Apps Development, Application Development Service.
Who are the key members and board of directors at Equilife Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ukha Singare  | Director | 14-Aug-2019 | Current |
| Dnyaneshwar Singare | Director | 14-Aug-2019 | Current |
| Shubhangi Pagar | Director | 23-Apr-2021 | Current |
Financial Performance of Equilife Laboratories.
Equilife Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 60.94% decrease. The company also saw a substantial fall in profitability, with a 422.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 87.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Equilife Laboratories?
In 2023, Equilife Laboratories had a promoter holding of 67.00% and a public holding of 33.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Knk Agro Producer Company LimitedShubhangi Pagar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Equilife Laboratories?
Unlock and access historical data on people associated with Equilife Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Equilife Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Equilife Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.